MedTrace Logo

Utilizing an EEG-Based BCI Game to Evaluate Cognitive Skills in Children With Motor Impairments

NCT07109830 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2026-05-07

No results posted yet for this study

Summary

This project aims to validate an EEG-based brain-computer interface (BCI) game as a cognitive assessment tool for children with motor impairments. Traditional cognitive assessments often rely on motor responses, which may underestimate the abilities of children with limited mobility. By using BCI technology, which captures brain activity directly, the study seeks to bypass these limitations and offer a more inclusive, engaging, and accurate assessment method.

The research consists of three papers:

1. Pilot Study: Tests the feasibility of the BCI game, comparing BCI and keyboard controls, and examines alignment with NEPSY-II cognitive subtests.
2. Validation Study: Investigates the convergent validity of the BCI game in typically developing children by correlating game performance with standardized cognitive test scores.
3. Adaptation Study: Compares game performance between neurotypical children and children with motor impairments to evaluate the game's inclusivity and adaptability.

The project utilizes the Emotiv Flex 2 EEG system and focuses on cognitive domains such as attention, working memory, and inhibition. The ultimate goal is to develop a reliable, equitable tool for assessing cognition in children with diverse motor abilities.

Conditions

  • Children With Motor Impairments

Interventions

DIAGNOSTIC_TEST

Cognitive assessment

Cognitive assessment using BCI-game

DIAGNOSTIC_TEST

NEPSY-II

Standardized cognitive assessment

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Eligibility

Min Age
7 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-11
Primary Completion
2026-08-31
Completion
2026-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07109830 on ClinicalTrials.gov